Dr John Melki – CEO and Director – Genetic Signatures (ASX:GSS) is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
Copyright 2023 – Finance News Network
Source: Finance News Network
30 Mar 2022 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses encouraging results in second-line non-small cell lung cancer.
Read More21 Sep 2023 - Ken Aitken - Managing Director - Metgasco (ASX:MEL) is a petroleum (oil and gas) exploration and production company, listed on the Australian Securities Exchange.
Read More01 Aug 2025 - AI platform revolutionising pharmaceutical quality control
Read More29 Mar 2021 - Telix Pharmaceuticals Limited (ASX:TLX) Chief Business Officer Dr David Cade talks about the company's clinical programs, including approvals, partnerships and significant value events anticipated in 2021.
Read More10 Jun 2021 - Calima Energy Limited (ASX:CE1) Executive Chairman Glenn Whiddon provides an update on production at the company's projects in British Columbia and its plans for an active, low-risk drilling program developing proven reserves.
Read More13 May 2025 - Cameron Cormack, Senior Portfolio Manager at VanEck, on ETF strategy and market outlook
Read More31 07 2024 - Amy Dickinson - Event Manager - Equity Events is a Brisbane based company which specialises in organising investment events for the mining, energy, exploration and industrial sectors.
Read More14 Jun 2023 - Australia holds the world's third largest amount of vanadium, behind China and Russia, but does not supply this critical mineral into the global market. Project Director Peter Hedley from Richmond Vanadium Technology (ASX:RVT) discusses the company's progress and the vanadium industry.
Read More12 Mar 2025 - Sofdra's rollout and the path to $100m revenue
Read More19 Aug 2022 - Sequoia Financial Group Limited (ASX:SEQ) Managing Director Garry Crole discusses FY22 financial highlights, future margin growth, acquisition strategy and dividend policy.
Read More
